Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Seattle, WA · Spokane, WA · +138 more sites
10 recruiting obesity studies with a site in Seattle, WA.
Sponsor: Amgen
Seattle, WA · Spokane, WA · +138 more sites
Sponsor: Eli Lilly and Company
Seattle, WA · Tacoma, WA · +48 more sites
Sponsor: University of Washington
Seattle, WA · +1 more sites
Sponsor: Novo Nordisk A/S
Renton, WA · Seattle, WA · +43 more sites
Sponsor: Ascletis Pharma (China) Co., Limited
Seattle, WA · +83 more sites
Sponsor: VA Office of Research and Development
Seattle, WA · +1 more sites
Sponsor: Seattle Institute for Biomedical and Clinical Research
Seattle, WA · Spokane, WA · +3 more sites
Sponsor: Rhythm Pharmaceuticals, Inc.
Seattle, WA · +7 more sites
Sponsor: University of Washington
Seattle, WA
Sponsor: Petter Bjornstad
Seattle, WA · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.